Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Cellestis, Inc., a prominent player in the biotechnology industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in the development of innovative diagnostic solutions, particularly in the field of infectious diseases and immune response testing.
With a focus on advanced immunology, Cellestis offers unique products such as the QuantiFERON® test, which is renowned for its accuracy in diagnosing latent tuberculosis infection. This test stands out due to its ability to provide results without the need for a return visit, streamlining the diagnostic process.
Cellestis has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. The company continues to drive advancements in diagnostic technology, contributing to improved patient outcomes globally.
+58 vs industry average
Cellestis, Inc.’s score of 100 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Cellestis, Inc. yet.
Cellestis, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Qiagen N.V., which means that any climate commitments or emissions data may be inherited from its parent organisation.
As part of its climate strategy, Cellestis, Inc. aligns with initiatives from Qiagen N.V., which has established various climate commitments. However, specific reduction targets or achievements for Cellestis, Inc. are not detailed in the available information. The company does not have documented reduction targets from the Science Based Targets initiative (SBTi) or other climate pledges.
Given the lack of direct emissions data and specific commitments, it is essential to monitor future disclosures from Cellestis, Inc. or its parent company, Qiagen N.V., for updates on their carbon emissions and climate action initiatives.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Cellestis, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Cellestis, Inc. yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more